Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Eastern Cooperative Oncology Group
UNC Lineberger Comprehensive Cancer Center
Inhibrx Biosciences, Inc
University of California, San Diego